UAB Launches New Schizophrenia Studies Targeting Glutamate
Wednesday, July 20, 2011 - 11:01
in Health & Medicine
UAB has received two grants totaling $3.9 million from the NIH to examine the role of the neurotransmitter glutamate in schizophrenia. Glutamate is linked to schizophrenia, but the nature of the link is unknown.